UCLA researchers featured at OncLive’s State of the Science Summit in Los Angeles
- Date: August 15, 2019 5:00 PM - 9:00 PM
- Location: Sofitel Los Angeles at Beverly Hills
8555 Beverly Blvd.
Los Angeles, California 90048
UCLA researchers are the featured speakers at OncLive’s “State of the Science Summit: The Treatment of Hematologic Malignancies” on Aug. 15 in Los Angeles.
At the evening summit, from 5:00 to 9:00 p.m. at the Sofitel Los Angeles at Beverly Hills, oncologists are invited to learn about UCLA’s latest research and treatment.
The discussion topics include: Hodgkin’s and non-Hodgkin’s lymphoma, frontline multiple myeloma, relapsed/refractory multiple myeloma, chronic lymphocytic leukemia, chronic myeloid leukemia, newly diagnosed acute myeloid leukemia, targeted therapy for acute myeloid leukemia, benign hematologic disorders, and CAR T. A peer exchange panel discussion with a question-and-answer session will also be part of the program.
The summit also is an opportunity for physicians to meet and network with colleagues from the area, along with the UCLA faculty. UCLA researchers featured at the summit include:
Gary Schiller, M.D.
Joshua Sasine, M.D., Ph.D.
Christopher Seet, M.D., Ph.D.
Sarah Larson, M.D.
John Timmerman, M.D.
Kanwarpal Kahlon, M.D.
Herbert Eradat, M.D.
The summit is presented by OncLive with support from the UCLA Jonsson Comprehensive Cancer Center. Registration is free of charge and refreshments will be provided. Learn more and register at: https://www.onclive.com/meetings/soss.